Everolimus
Cat.No:IE0710 Solarbio
CAS:159351-69-6
Molecular Formula:C53H83NO14
Molecular Weight:958.22
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
PI3K/Akt/mTOR >
EverolimusCAS:159351-69-6
Molecular Formula:C53H83NO14
Molecular Weight:958.22
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 159351-69-6 |
Name | Everolimus |
Molecular Formula | C53H83NO14 |
Molecular Weight | 958.22 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 621-003-9 |
MDL | MFCD00929329 |
SMILES | O=C([C@@]1(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@@H](C)C([C@@H]([C@@H](/C(C)=C/[C@H]2C)O)OC)=O)C)OC)O1)C)C(N3CCCC[C@H]3C(O[C@@H](CC2=O)[C@@H](C[C@H]4C[C@H]([C@H](OCCO)CC4)OC)C)=O)=O |
Target Point | mTOR |
Passage | PI3K/Akt/mTOR |
Background | Everolimus is a potent mTOR inhibitor. |
Biological Activity | Everolimus (RAD001) 是有效的 mTOR 抑制剂, 它与FKBP-12结合以产生免疫抑制复合物[1-4]。 |
IC50 | mTOR:5-6nM (IC50) [1-4] |
Data Literature Source | [1]. O'Reilly T, et al. Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001) : Processes,Limitations, and Further Proposals. Transl Oncol. 2010 Apr; 3 (2) :65-79. [2]. Lane HA, et al. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Clin Cancer Res, 2009, 15 (5) , 1612-1622. [3]. Zhu Y, et al. Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo. Tumour Biol. 2012 Oct; 33 (5) :1349-62. [4]. Kawata T, et al. Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia. Cancer Sci. 2018 Jan; 109 (1) :103-111. |
Unit | Bottle |
Specification | 5mg 10mg 50mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.